Concept information
Preferred term
Trimethoprim, Sulfamethoxazole Drug Combination
Type
-
mesh:Descriptor
Definition
- A drug combination with broad-spectrum antibacterial activity against both gram-positive and gram-negative organisms. It is effective in the treatment of many infections, including PNEUMOCYSTIS PNEUMONIA in AIDS.
Broader concept
Entry terms
- 8064-90-2
- Benzenesulfonamide, 4-a)mino-N-(5-methyl-3-isoxazolyl)-, mixt. with 5-((3,4,5-trimethoxyphenyl)methyl-2,4-pyrimidinediamine
- Centran
- Centrin
- Co-Trimoxazole
- Cotrimoxazole
- Eslectin
- Insozalin
- Sulfamethoxazole-Trimethoprim Combination
- TMP SMX
- TMP-SMX
- Trimedin
- Trimethoprim-Sulfamethoxazole
- Trimethoprim-Sulfamethoxazole Combination
- Trimezole
Allowable Qualifier(s)
- administration & dosage (Qualifier)
- adverse effects (Qualifier)
- agonists (Qualifier)
- analysis (Qualifier)
- antagonists & inhibitors (Qualifier)
- blood (Qualifier)
- cerebrospinal fluid (Qualifier)
- chemical synthesis (Qualifier)
- chemistry (Qualifier)
- classification (Qualifier)
- economics (Qualifier)
- history (Qualifier)
- immunology (Qualifier)
- isolation & purification (Qualifier)
- metabolism (Qualifier)
- pharmacokinetics (Qualifier)
- pharmacology (Qualifier)
- poisoning (Qualifier)
- radiation effects (Qualifier)
- standards (Qualifier)
- supply & distribution (Qualifier)
- therapeutic use (Qualifier)
- toxicity (Qualifier)
- urine (Qualifier)
Pharmacological Action(s)
In other languages
-
French
-
8064-90-2
-
Benzenesulfonamide, 4-a)mino-N-(5-methyl-3-isoxazolyl)-, mixt. with 5-((3,4,5-trimethoxyphenyl)methyl-2,4-pyrimidinediamine
-
TMP-SMX
-
TMPSMX
URI
http://data.loterre.fr/ark:/67375/JVR-CK6TT8N4-X
{{label}}
{{#each values }} {{! loop through ConceptPropertyValue objects }}
{{#if prefLabel }}
{{/if}}
{{/each}}
{{#if notation }}{{ notation }} {{/if}}{{ prefLabel }}
{{#ifDifferentLabelLang lang }} ({{ lang }}){{/ifDifferentLabelLang}}
{{#if vocabName }}
{{ vocabName }}
{{/if}}